Full Text
COST EFFECTIVENESS OF DAPAGLIFLOZIN/METFORMIN VERSUS GLIBENCLAMIDE/METFORMIN FOR THE TREATMENT OF TYPE 2 DIABETES IN CHILE

Abstract

Authors

R. Rojas C. Vargas C. Balmaceda M.A. Espinoza

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×